EPO Patents = 1

Trademarks = 2

Forward Citations = 23

Loading Chart...

7 inventors (with patents filed for the assignee):

Steven C Quay (8 out of 93 patents)

Yao-Lin Sun (7 out of 7 patents)

LungHu Wang (7 out of 9 patents)

4. ChangJung Wu (7 out of 7 patents)

5. ChuanDer Huang (7 out of 7 patents)

6. Naresh Kumar Reddy Vutukuru (1 out of 3 patents)

7. Srinivasan Shanmugam (1 out of 3 patents)

8. Edward Thomas Kisak (23 patents)

9. John Michael Newsam (30 patents)

10. Avadhesh S Kushwaha (0 patent)

8 patents: Sort by Forward Citations

1. 12479790 - Methods for making and using endoxifen (2025-11-25),

2. 12281056 - Methods for making and using endoxifen (2025-04-21),

3. 12275684 - Methods for making and using endoxifen (2025-04-14),

4. 12201591 - Sustained release compositions of endoxifen (2025-01-21),

5. 12071391 - Methods for making and using endoxifen (2024-08-27),

6. 11680036 - Methods for making and using endoxifen (2023-06-20),

7. 11572334 - Methods for making and using endoxifen (2023-02-07),

8. 11261151 - Methods for making and using endoxifen (2022-03-01),

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing innovative treatments for breast cancer and other breast conditions. Their pipeline includes drug candidates aimed at reducing the recurrence of breast cancer and improving outcomes for patients. Atossa Therapeutics is dedicated to improving the lives of those affected by breast cancer through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

8 Patents

#224 in Seattle, WA

#782 in Washington

#34,869 in US

Seattle, WA, United States of America

Atossa Therapeutics, Inc.